Author

Joan Teyra

Icosagen (Estonia)ORCID 0000-0003-2816-339XUnclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Joan Teyra1 paper

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:protein structure· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Adam J. MiddletoniD· 1 shared Alain TedguiiD· 1 shared Catherine L. DayiD· 1 shared Céline AlbalaaiD· 1 shared Christoph J. BinderiD· 1 shared David KlatzmanniD· 1 shared Fatima Saddouk· 1 shared Florentina PorschiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Adam J. MiddletonORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintSep 15, 2026

Targeting IL-2 to inflamed tissues via oxidation-specific epitopes enables third-generation bispecific IL-2 therapeutics

Thomas Vazquez, Monica Cuevas-martinez, Nicolas Billiald…·David Klatzmann

This paper develops a third-generation IL-2 therapeutic that targets inflamed tissues via oxidation-specific epitopes, showing improved therapeutic benefit in multiple inflammation models.

DOI 10.64898/2026.09.10.750022

𝕏 PostBluesky

BiochemistryFEBS JournalPeer-reviewedOct 29, 2024

Structural and biophysical characterisation of ubiquitin variants that specifically inhibit the ubiquitin conjugating enzyme Ube2d2

Jeffery M. R. B. McAlpine, Jingyi Zhu, Nicholas Pudjihartono…·Adam J. Middleton

The paper identifies ubiquitin variants that inhibit Ube2d2, showing structural and biophysical properties that suggest potential for developing selective E2 enzyme inhibitors.

2 citations

protein structureexperimental assay

𝕏 PostBluesky